Exoskeleton developer Wandercraft raised $45M in funding

Take heed to this text

Atalante is a lower-body exoskeleton used for rehabilitation. | Supply: Wandercraft

Wandercraft, a Paris-based developer of exoskeletons, raised $45 million in Collection C funding. The corporate plans to make use of the funding to develop and launch a private exoskeleton for out of doors and residential use, in addition to to speed up the deployment of Atalante, Wandercraft’s rehabilitation exoskeleton, in the US.

Atalante is a self-balanced, lower-body exoskeleton that emulates the best way people stroll. The corporate started medical trials for the exoskeleton in 2017. It was CE marked in 2019.

The exoskeleton is designed to permit the wearer to freely transfer their higher physique and torso with the corporate’s hands-free characteristic. The exoskeleton is used to assist bodily remedy sufferers stroll quicker and with extra ease.

“We’re tremendous excited to have attracted world-class traders from the USA and Europe to advance the event program of the corporate,” Matthieu Masselin, CEO of Wandercraft, stated. “With the help of sufferers, medical professionals and the DeepTech neighborhood, Wandercraft’s staff has created a novel know-how that improves rehabilitation care and can quickly allow folks in wheelchairs to regain autonomy and enhance their on a regular basis well being.”

The funding spherical was led by Quadrant Administration, an funding agency primarily based in New York. It included participation from Bpifrance, SofiOuest, XAnge, Eurazeo, LBO France and Cemag Make investments. A part of the funding additionally got here from medical insurance corporations like MACSF, Malakoff Humanis, AG2R La Mondiale and Mutuelle Affect.

“Wandercraft has succeeded in growing a revolutionary exoskeleton for the remedy of sufferers whose day by day autonomy has been impaired,” Stanislas Subra, head of investments at MACSF Group and a member of Wandercraft’s board of administrators, stated. “It is just becoming that we’re delighted to take part within the speedy improvement of a French innovation alongside healthcare professionals.”

Wandercraft additionally introduced that Alan Quasham, the chairman and CEO of Quadrant Administration, is becoming a member of Wandercraft’s board of administrators.